MicroRNA-206 Reduces Osteosarcoma Cell Malignancy In Vitro by Targeting the PAX3-MET Axis.

CONCLUSION: miR-206 reduces OS cell malignancy in vitro by targeting PAX3 and MET gene expression.
PMID: 30666838 [PubMed - in process]

Source: Yonsei Medical Journal - January 24, 2019 Category: Universities & Medical Training Authors: Zhan FB, Zhang XW, Feng SL, Cheng J, Zhang Y, Li B, Xie LZ, Deng QR Tags: Yonsei Med J Source Type: research